115 related articles for article (PubMed ID: 38775951)
1. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients.
Green M; Williams L; Boh E; Kuraitis D
Arch Dermatol Res; 2024 May; 316(5):194. PubMed ID: 38775951
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
Eo DR; Lee MG; Ham DI; Kang SW; Lee J; Cha HS; Koh E; Kim SJ
J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
[TBL] [Abstract][Full Text] [Related]
3. Effects of hydroxychloroquine treatment on QT interval.
Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
[TBL] [Abstract][Full Text] [Related]
4. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
[TBL] [Abstract][Full Text] [Related]
5. The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle.
Overbury RS; Stoddard GJ; Pupaibool J; Hansen CB; Lebiedz-Odrobina D
BMC Health Serv Res; 2021 Sep; 21(1):913. PubMed ID: 34479563
[TBL] [Abstract][Full Text] [Related]
6. Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
Rekedal LR; Massarotti E; Garg R; Bhatia R; Gleeson T; Lu B; Solomon DH
Arthritis Rheum; 2010 Dec; 62(12):3569-73. PubMed ID: 20722019
[TBL] [Abstract][Full Text] [Related]
7. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.
Rosenbaum JT; Costenbader KH; Desmarais J; Ginzler EM; Fett N; Goodman SM; O'Dell JR; Schmajuk G; Werth VP; Melles RB; Marmor MF
Arthritis Rheumatol; 2021 Jun; 73(6):908-911. PubMed ID: 33559327
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
9. Desensitization to hydroxychloroquine--experience of 4 patients.
Mates M; Zevin S; Breuer GS; Navon P; Nesher G
J Rheumatol; 2006 Apr; 33(4):814-6. PubMed ID: 16463436
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
Gianfrancesco MA; Schmajuk G; Haserodt S; Trupin L; Izadi Z; Jafri K; Shiboski S; Sirota M; Dudley RA; Yazdany J
Rheumatol Int; 2017 Oct; 37(10):1611-1618. PubMed ID: 28748425
[TBL] [Abstract][Full Text] [Related]
11. Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.
Mohammad S; Clowse MEB; Eudy AM; Criscione-Schreiber LG
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):481-485. PubMed ID: 28556555
[TBL] [Abstract][Full Text] [Related]
12. Pericentral hydroxychloroquine retinopathy in Korean patients.
Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of antimalarial drugs in rheumatic diseases.
Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS
Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of hydroxychloroquine-induced side-effects in dermatology patients: A retrospective survey of 102 patients].
Tétu P; Hamelin A; Lebrun-Vignes B; Soria A; Barbaud A; Francès C; Chasset F
Ann Dermatol Venereol; 2018; 145(6-7):395-404. PubMed ID: 29792286
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update.
Abdulaziz N; Shah AR; McCune WJ
Curr Opin Rheumatol; 2018 May; 30(3):249-255. PubMed ID: 29517495
[TBL] [Abstract][Full Text] [Related]
16. [Application and safety of hydroxychloroquine in chronic disease among children].
Sun L; Gong YR; Chen Q; Zhang T; Li GM; Liu HM; Yang CH; Qian LL; Li YF; Yao W; Xu H
Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):107-112. PubMed ID: 33548956
[No Abstract] [Full Text] [Related]
17. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Hydroxychloroquine Dosing Guidelines by Rheumatologists: An Electronic Medical Record-Based Study in an Integrated Health Care System.
Braslow RA; Shiloach M; Macsai MS
Ophthalmology; 2017 May; 124(5):604-608. PubMed ID: 28153440
[TBL] [Abstract][Full Text] [Related]
19. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
